FDA alters Label on Quit-Smoking Drug Chantix

March 11, 2015 1:33 PM

15 0

The FDA has altered the label on the quit-smoking drug Chantix for creating awareness and address the concern over its potential to lower one’s tolerance level on alcohol and association with an annual risk of seizures.

The FDA warns, “Until patients know how Chantix affects their ability to tolerate alcohol, they should decrease the amount of alcohol they drink. Patients who have a seizure while taking Chantix should stop the medicine and seek medical attention immediately”.

Read more

To category page